| Rhinovirus (n = 23) | RSV (n = 27) | P |
---|---|---|---|
Age, years | 1.4 (0.59) | 0.78 (0.61) | 0.0012 |
Male, No. | 15 (65%) | 16 (59%) | 0.67 |
Atopic, No. | 10 (44%) | 1 (4%) | 0.0009 |
   Food sensitization, No | 9 (39%) | 1 (4%) | 0.0034 |
   Perennial aeroallergen, No. | 1 (4%) | 0 (0%) | 0.47 |
1st episode, No. | 17 (74%) | 25 (93%) | 0.12 |
2nd episode, No. | 6 (26%) | 2 (7%) | 0.12 |
Parental asthma, No. | 2 (9%) | 6 (22%) | 0.26 |
Parental allergy, No. | 13 (57%) | 16 (59%) | 0.85 |
Parental smoking, No. | 11 (48%) | 14 (52%) | 0.78 |
Previous symptoms | Â | Â | Â |
   Cough, days | 2 (1, 3) | 4 (3, 5) | 0.0072 |
   Wheezing, days | 1 (1, 1) | 2 (2, 3) | 0.053 |
On entry to the study | Â | Â | Â |
   RSS, points (0, none to 12, severe) | 6.7 (1.4) | 6.5 (1.1) | 0.45 |
   O2-saturation, % | 96 (2.3) | 96 (2.5) | 0.75 |
   Acute otitis media, No. | 11 (48%) | 21 (78%) | 0.028 |
   Blood eosinophils, × 109/L | 0.4 (0.2, 0.6) | 0.0 (0.0, 0.1) | <0.0001 |
   Blood eosinophils >0.1 × 109/L | 20 (87%) | 3/26 (12%) | <0.0001 |
   Exhaled nitric oxide, ppb1 | 7.5 (7.0, 12) | 5.1 (3.9, 6.5) | 0.020 |
Medication | Â | Â | Â |
   Salbutamol at ER before entry, mg/kg | 0.23 (0.18) | 0.19 (0.17) | 0.46 |
   Antibiotic treatment, No. | 15 (65%) | 21 (78%) | 0.013 |